EP Patent

EP2155169A2 — Extended release formulation of nevirapine

Assigned to Boehringer Ingelheim International GmbH · Expires 2010-02-24 · 16y expired

What this patent protects

The invention relates to an extended release pharmaceutical composition comprising nevirapine.

USPTO Abstract

The invention relates to an extended release pharmaceutical composition comprising nevirapine.

Drugs covered by this patent

Viramune (NEVIRAPINE) · Boehringer Ingelheim

Patent Metadata

Patent number: EP2155169A2
Jurisdiction: EP
Classification: —
Expires: 2010-02-24
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.